Exploring serum and immunoglobulin G Nglycome as diagnostic biomarkers for early detection of breast cancer in Ethiopian women

Alterations in protein glycosylation patterns have potentially been targeted for biomarker discovery in a wide range of diseases including cancer. Although there have been improvements in patient diagnosis and survival for breast cancer (BC), there is no clinically validated serum biomarker for its early diagnosis.